Reference number : 276-2020-2021-Q1-00329, amendment number : , agreement type : C, recipient legal name : Solid State Pharma Inc.|Solid State Pharma Inc., recipient country : CA, recipient province : NS, recipient city : Halifax|Halifax, recipient postal code : B3J 3M5, program name english : REGI - Business Scale-up and Productivity, program name french : CERI - Expansion et productivite des entreprises, program purpose english : nan, program purpose french : nan, agreement title english : 215125, agreement title french : 215125, agreement number : 215125, agreement value : 75000.0, agreement start date : 2020-06-10, agreement end date : 2021-03-31, description english : Develop synthetic route for reagents crucial to COVID-19 testing, description french : Créer un procédé de synthèse pour les réactifs essentiels au dépistage de la COVID-19, expected results english : nan, expected results french : nan, additional information english : The assistance type is Unconditionally Repayable Contribution., additional information french : Le type d'aide est contribution à remboursement inconditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique